Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR01 Zidovudine and lamivudine
D07507 Zidovudine and lamivudine <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Combinations
Lamivudine/ Zidovudine
D07507 Zidovudine and lamivudine
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D07507 Zidovudine and lamivudine
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D07507 Zidovudine and lamivudine
DG03107 Anti-HIV agent
D07507 Zidovudine and lamivudine
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D07507 Zidovudine and lamivudine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D07507 Zidovudine and lamivudine <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07507